Abstract
In this study, the intracellular signal transduction pathways leading to the production of TNF-alpha and superoxide anions by amyloid-beta-stimulated primary human monocyte-derived macrophages was investigated. Using Western blotting and specific inhibitors it is shown that both ERK 1/2 and p38 MAPK signal transduction pathways as well as PKC are involved in the amyloid-beta-stimulated superoxide anion production. In contrast, only ERK 1/2 MAPK seems to be involved in TNF-alpha production: questioning the connection between PKC and ERK 1/2 activation. Our results suggest the use of ERK 1/2 MAPK inhibitors in the prevention of macrophage activation in the context of Alzheimer's disease.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amyloid beta-Peptides / pharmacology*
-
Cells, Cultured
-
Enzyme Inhibitors / pharmacology
-
Humans
-
Macrophages / cytology
-
Macrophages / drug effects*
-
Macrophages / metabolism*
-
Mitogen-Activated Protein Kinase 1 / antagonists & inhibitors
-
Mitogen-Activated Protein Kinase 1 / metabolism
-
Mitogen-Activated Protein Kinase 3
-
Mitogen-Activated Protein Kinases / antagonists & inhibitors
-
Mitogen-Activated Protein Kinases / metabolism
-
Peptide Fragments / pharmacology*
-
Protein Kinase C / antagonists & inhibitors
-
Protein Kinase C / metabolism
-
Second Messenger Systems / drug effects
-
Second Messenger Systems / physiology*
-
Signal Transduction / drug effects
-
Signal Transduction / physiology
-
Superoxides / metabolism*
-
Tumor Necrosis Factor-alpha / metabolism*
-
p38 Mitogen-Activated Protein Kinases
Substances
-
Amyloid beta-Peptides
-
Enzyme Inhibitors
-
Peptide Fragments
-
Tumor Necrosis Factor-alpha
-
amyloid beta-protein (1-42)
-
Superoxides
-
Protein Kinase C
-
Mitogen-Activated Protein Kinase 1
-
Mitogen-Activated Protein Kinase 3
-
Mitogen-Activated Protein Kinases
-
p38 Mitogen-Activated Protein Kinases